Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Combination of sequence‐defined oligoaminoamides with transferrin‐polycation conjugates for receptor‐targeted gene delivery

Identifieur interne : 000F69 ( Main/Exploration ); précédent : 000F68; suivant : 000F70

Combination of sequence‐defined oligoaminoamides with transferrin‐polycation conjugates for receptor‐targeted gene delivery

Auteurs : Wei Zhang [Allemagne] ; Wolfgang Rödl [Allemagne] ; Dongsheng He [Allemagne] ; Markus Döblinger [Allemagne] ; Ulrich L Chelt [Allemagne] ; Ernst Wagner [Allemagne]

Source :

RBID : ISTEX:8DB4A2E563BAFAF8DB1967800126A49401D53C10

Abstract

Background: Transferrin receptor (TfR), over‐expressed on a majority of malignant cells, has been widely studied as a target for drug, protein and gene delivery. Both stable nucleic acid compact ability and efficient cytosol gene release capability are essential for the success of gene delivery. Methods: In the present study, a novel nonviral TfR‐targeted gene delivery system was developed based on sequence‐defined cationic oligoaminoamide oligomers with endolysosomal buffer capacity and DNA binding transferrin (Tf) polycation conjugates. Results: Gene transfer activities were significantly increased in a series of TfR over‐expressing human tumour cell lines (K562, DU145 and KB) with mixed ternary polyplexes containing Tf‐conjugates and 3‐arm (386 and 689) or 4‐arm (577, 579 and 607) sequence‐defined oligomers. Especially polyplexes containing a histidine‐rich 4‐arm oligomer (607) and Tf‐PEG‐PEI achieved a 100‐fold increase in gene expression compared to previously established formulations. Tf competition experiments indicate enhanced polyplex internalization via TfR as prerequisite for the high transfection activity. The additional histidines in the oligoaminoamide oligomer structure are required for more effective endolysosomal escape of the gene delivery vehicle. Polyplexes formed by first mixing pDNA with the oligomer as a cationic core, followed by the addition of the Tf‐polycation conjugate for presentation at the exterior nanoparticles, exhibited the highest transfection activity. Conclusions: Utilizing the synergistic effects of Tf for receptor targeting and oligomer for packaging and endolysosomal escape, an efficient gene delivery carrier was developed. The mixed polyplex containing Tf‐polycation conjugates and histidinylated 4‐arm oligomer with succinoyl tetraethylene pentamine or glutaroyltriethylene tetramine building blocks exhibited the highest gene transfection efficiency in TfR over‐expressing human tumour cell lines. Copyright © 2015 John Wiley & Sons, Ltd.

Url:
DOI: 10.1002/jgm.2838


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Combination of sequence‐defined oligoaminoamides with transferrin‐polycation conjugates for receptor‐targeted gene delivery</title>
<author>
<name sortKey="Zhang, Wei" sort="Zhang, Wei" uniqKey="Zhang W" first="Wei" last="Zhang">Wei Zhang</name>
</author>
<author>
<name sortKey="Rodl, Wolfgang" sort="Rodl, Wolfgang" uniqKey="Rodl W" first="Wolfgang" last="Rödl">Wolfgang Rödl</name>
</author>
<author>
<name sortKey="He, Dongsheng" sort="He, Dongsheng" uniqKey="He D" first="Dongsheng" last="He">Dongsheng He</name>
</author>
<author>
<name sortKey="Doblinger, Markus" sort="Doblinger, Markus" uniqKey="Doblinger M" first="Markus" last="Döblinger">Markus Döblinger</name>
</author>
<author>
<name sortKey="L Chelt, Ulrich" sort="L Chelt, Ulrich" uniqKey="L Chelt U" first="Ulrich" last="L Chelt">Ulrich L Chelt</name>
</author>
<author>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8DB4A2E563BAFAF8DB1967800126A49401D53C10</idno>
<date when="2015" year="2015">2015</date>
<idno type="doi">10.1002/jgm.2838</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-J8CNN8W0-X/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001559</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001559</idno>
<idno type="wicri:Area/Istex/Curation">001559</idno>
<idno type="wicri:Area/Istex/Checkpoint">000114</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000114</idno>
<idno type="wicri:doubleKey">1099-498X:2015:Zhang W:combination:of:sequence</idno>
<idno type="wicri:Area/Main/Merge">000F70</idno>
<idno type="wicri:Area/Main/Curation">000F69</idno>
<idno type="wicri:Area/Main/Exploration">000F69</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Combination of sequence‐defined oligoaminoamides with transferrin‐polycation conjugates for receptor‐targeted gene delivery</title>
<author>
<name sortKey="Zhang, Wei" sort="Zhang, Wei" uniqKey="Zhang W" first="Wei" last="Zhang">Wei Zhang</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Pharmaceutical Biotechnology, Centre for System‐Based Drug Research, Ludwig‐Maximilians‐Universität Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rodl, Wolfgang" sort="Rodl, Wolfgang" uniqKey="Rodl W" first="Wolfgang" last="Rödl">Wolfgang Rödl</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Pharmaceutical Biotechnology, Centre for System‐Based Drug Research, Ludwig‐Maximilians‐Universität Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="He, Dongsheng" sort="He, Dongsheng" uniqKey="He D" first="Dongsheng" last="He">Dongsheng He</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Pharmaceutical Biotechnology, Centre for System‐Based Drug Research, Ludwig‐Maximilians‐Universität Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Nanosystems Initiative Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Doblinger, Markus" sort="Doblinger, Markus" uniqKey="Doblinger M" first="Markus" last="Döblinger">Markus Döblinger</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Chemistry, Ludwig‐Maximilians‐Universität Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="L Chelt, Ulrich" sort="L Chelt, Ulrich" uniqKey="L Chelt U" first="Ulrich" last="L Chelt">Ulrich L Chelt</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Pharmaceutical Biotechnology, Centre for System‐Based Drug Research, Ludwig‐Maximilians‐Universität Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Nanosystems Initiative Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Pharmaceutical Biotechnology, Centre for System‐Based Drug Research, Ludwig‐Maximilians‐Universität Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Nanosystems Initiative Munich, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">The Journal of Gene Medicine</title>
<title level="j" type="alt">THE JOURNAL OF GENE MEDICINE</title>
<idno type="ISSN">1099-498X</idno>
<idno type="eISSN">1521-2254</idno>
<imprint>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">8-9</biblScope>
<biblScope unit="page" from="161">161</biblScope>
<biblScope unit="page" to="172">172</biblScope>
<biblScope unit="page-count">12</biblScope>
<date type="published" when="2015-08-09">2015-08-09</date>
</imprint>
<idno type="ISSN">1099-498X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1099-498X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Background: Transferrin receptor (TfR), over‐expressed on a majority of malignant cells, has been widely studied as a target for drug, protein and gene delivery. Both stable nucleic acid compact ability and efficient cytosol gene release capability are essential for the success of gene delivery. Methods: In the present study, a novel nonviral TfR‐targeted gene delivery system was developed based on sequence‐defined cationic oligoaminoamide oligomers with endolysosomal buffer capacity and DNA binding transferrin (Tf) polycation conjugates. Results: Gene transfer activities were significantly increased in a series of TfR over‐expressing human tumour cell lines (K562, DU145 and KB) with mixed ternary polyplexes containing Tf‐conjugates and 3‐arm (386 and 689) or 4‐arm (577, 579 and 607) sequence‐defined oligomers. Especially polyplexes containing a histidine‐rich 4‐arm oligomer (607) and Tf‐PEG‐PEI achieved a 100‐fold increase in gene expression compared to previously established formulations. Tf competition experiments indicate enhanced polyplex internalization via TfR as prerequisite for the high transfection activity. The additional histidines in the oligoaminoamide oligomer structure are required for more effective endolysosomal escape of the gene delivery vehicle. Polyplexes formed by first mixing pDNA with the oligomer as a cationic core, followed by the addition of the Tf‐polycation conjugate for presentation at the exterior nanoparticles, exhibited the highest transfection activity. Conclusions: Utilizing the synergistic effects of Tf for receptor targeting and oligomer for packaging and endolysosomal escape, an efficient gene delivery carrier was developed. The mixed polyplex containing Tf‐polycation conjugates and histidinylated 4‐arm oligomer with succinoyl tetraethylene pentamine or glutaroyltriethylene tetramine building blocks exhibited the highest gene transfection efficiency in TfR over‐expressing human tumour cell lines. Copyright © 2015 John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement>
<li>Munich</li>
</settlement>
</list>
<tree>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Zhang, Wei" sort="Zhang, Wei" uniqKey="Zhang W" first="Wei" last="Zhang">Wei Zhang</name>
</region>
<name sortKey="Doblinger, Markus" sort="Doblinger, Markus" uniqKey="Doblinger M" first="Markus" last="Döblinger">Markus Döblinger</name>
<name sortKey="He, Dongsheng" sort="He, Dongsheng" uniqKey="He D" first="Dongsheng" last="He">Dongsheng He</name>
<name sortKey="He, Dongsheng" sort="He, Dongsheng" uniqKey="He D" first="Dongsheng" last="He">Dongsheng He</name>
<name sortKey="L Chelt, Ulrich" sort="L Chelt, Ulrich" uniqKey="L Chelt U" first="Ulrich" last="L Chelt">Ulrich L Chelt</name>
<name sortKey="L Chelt, Ulrich" sort="L Chelt, Ulrich" uniqKey="L Chelt U" first="Ulrich" last="L Chelt">Ulrich L Chelt</name>
<name sortKey="Rodl, Wolfgang" sort="Rodl, Wolfgang" uniqKey="Rodl W" first="Wolfgang" last="Rödl">Wolfgang Rödl</name>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F69 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F69 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:8DB4A2E563BAFAF8DB1967800126A49401D53C10
   |texte=   Combination of sequence‐defined oligoaminoamides with transferrin‐polycation conjugates for receptor‐targeted gene delivery
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021